Socialiya - Entertainment. Knowledge. Community.
Oruka’s psoriasis data hailed as ‘outright win over Skyrizi,’ spurring big blockbuster forecasts

Oruka Therapeutics' long-acting plaque psoriasis candidate cleared the skin of 63.5% of patients in...

BUSINESS NEWS April 27, 2026

Oruka’s psoriasis data hailed as ‘outright win over Skyrizi,’ spurring big blockbuster forecasts

Oruka Therapeutics' long-acting plaque psoriasis candidate cleared the skin of 63.5% of patients in a phase 2a trial, leading Jefferies analysts to predict...

8 views 0 likes 0 comments
Share:
Oruka Therapeutics' long-acting plaque psoriasis candidate cleared the skin of 63.5% of patients in a phase 2a trial, leading Jefferies analysts to predict...

Author: Fierce Biotech

Read Original Article

Related News

Advertisement
APNA POS
Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
APNA POS
Advertisement
socialiya